118 related articles for article (PubMed ID: 1445889)
1. Requirement of zymogen modification for activation of porcine plasminogen.
Machovich R; Litwiller RD; Owen WG
Biochemistry; 1992 Nov; 31(46):11558-61. PubMed ID: 1445889
[TBL] [Abstract][Full Text] [Related]
2. 6-aminohexanoate and chloride ion in the activation by urokinase of porcine plasminogens.
Machovich R; Owen WG
Biochim Biophys Acta; 1990 Aug; 1040(1):109-11. PubMed ID: 2378895
[TBL] [Abstract][Full Text] [Related]
3. Facilitation of plasminogen activation by a plasmin substrate containing a lysyl residue.
Machovich R; Owen WG
Thromb Haemost; 1993 Nov; 70(5):864-6. PubMed ID: 8128447
[TBL] [Abstract][Full Text] [Related]
4. The roles of native milk proteinase and its zymogen during proteolysis in normal bovine milk.
de Rham O; Andrews AT
J Dairy Res; 1982 Nov; 49(4):577-85. PubMed ID: 6217233
[TBL] [Abstract][Full Text] [Related]
5. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
Petersen LC; Brender J; Suenson E
Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638
[TBL] [Abstract][Full Text] [Related]
6. Denatured proteins as cofactors for plasminogen activation.
Machovich R; Owen WG
Arch Biochem Biophys; 1997 Aug; 344(2):343-9. PubMed ID: 9264548
[TBL] [Abstract][Full Text] [Related]
7. Dual effect of synthetic plasmin substrates on plasminogen activation.
Kolev K; Owen WG; Machovich R
Biochim Biophys Acta; 1995 Mar; 1247(2):239-45. PubMed ID: 7696314
[TBL] [Abstract][Full Text] [Related]
8. An elastase-dependent pathway of plasminogen activation.
Machovich R; Owen WG
Biochemistry; 1989 May; 28(10):4517-22. PubMed ID: 2504279
[TBL] [Abstract][Full Text] [Related]
9. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
Husain SS
Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil proteases in plasminogen activation.
Machovich R; Himer A; Owen WG
Blood Coagul Fibrinolysis; 1990 Aug; 1(3):273-7. PubMed ID: 1715763
[TBL] [Abstract][Full Text] [Related]
11. Modulation of plasminogen activation and plasmin activity by methylglyoxal modification of the zymogen.
Léránt I; Kolev K; Gombás J; Machovich R
Biochim Biophys Acta; 2000 Jul; 1480(1-2):311-20. PubMed ID: 10899632
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
[TBL] [Abstract][Full Text] [Related]
13. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
14. The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation.
Walther PJ; Hill RL; McKee PA
J Biol Chem; 1975 Aug; 250(15):5926-33. PubMed ID: 1150667
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
16. Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).
Fears R; Dodd I; Ferres H; Robinson JH
Biochem J; 1990 Mar; 266(3):693-6. PubMed ID: 2139324
[TBL] [Abstract][Full Text] [Related]
17. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
Robbins KC; Tanaka Y
Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
[TBL] [Abstract][Full Text] [Related]
18. Proenzyme to urokinase-type plasminogen activator in human colon cancer: in vitro inhibition by monocyte minactivin after proteolytic activation.
Stephens RW; Fordham CJ; Doe WF
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):213-22. PubMed ID: 2965017
[TBL] [Abstract][Full Text] [Related]
19. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
Hunt JA; Petteway SR; Scuderi P; Novokhatny V
Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
